CNS Disorders  >>  Korlym (mifepristone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Korlym (mifepristone) / Corcept Therap
NCT00105105: Mifepristone as Adjunctive Therapy in Alzheimer's Disease

Terminated
2
160
US
Mifepristone
Corcept Therapeutics, Institute for the Study of Aging (ISOA)
Alzheimer's Disease
11/05
11/05
NCT01739335: Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone

Completed
2
81
US
Mifepristone Oral Tablet [Korlym], Korlym, Placebo Oral Tablet, Sugar pill
VA Office of Research and Development
Stress Disorders, Post-Traumatic
09/16
11/16
RESET-m, NCT05217758: edication Glucocorticoid Receptor (GR) Blockade as Disease Modifying Treatment for Depression With Childhood Trauma

Recruiting
2
158
Europe
Mifepristone, Placebo
VU University Medical Center, Netherlands Brain Foundation, Corcept Therapeutics
Major Depressive Disorder, Childhood Trauma
12/23
06/24

Download Options